πŸ‡ΊπŸ‡Έ FDA
Patent

US 11548890

HPK1 antagonists and uses thereof

granted A61PA61P31/00A61P35/00

Quick answer

US patent 11548890 (HPK1 antagonists and uses thereof) held by Nimbus Saturn, Inc. expires Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nimbus Saturn, Inc.
Grant date
Tue Jan 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61P, A61P31/00, A61P35/00